REVIEWS |
|
E.A. Degtiareva, S.A. Protsenko, E.N. Imyanitov
Rare immuno-mediated adverse events: literature review
|
8-14 |
T.Yu. Semiglazova (1, 2), V.V. Semiglazov (1, 3), V.V. Klimenko (1), N.A. Brish (1), Yu.V. Alekseeva (1), V.A. Klyuge (1), A.A. Krutov (1), R.M. Paltuev (1), B.S. Kasparov (1), P.V. Krivorotko (1, 2), V.F. Semiglazov (1, 2)
Alpelisib for the treatment of HR+HER2-metastatic breast cancer in patients with the PIK3CA mutation: results of the SOLAR-1 study
|
15-23 |
L.E. Gurevich, E.V. Bondarenko, V.E. Ashevskaya, D.N. Fedorov
The role of multidisciplinary centers in the diagnosis and treatment of neuroendocrine tumors: the experience of the Russian Expert Center for the morphological diagnosis of neuroendocrine tumors of the digestive tract at the M.F. Vladimirsky Moscow Regional Research Clinical Institute (MONIKI)
|
24-33 |
T.Yu. Semiglazova (1, 2), V.A. Zagoruyko (1), A.G. Radzhabova (1), E.V. Tkachenko (1), G.M. Teletaeva (1), D.Kh. Latipova (1), A.I. Semenova (1), V.V. Semiglazov (1, 3), L.V. Filatova (1), S.A. Protsenko (1)
Prospects for the use of immunotherapy in the treatment of head and neck squamous cell carcinoma
|
34-40 |
ORIGINAL ARTICLES |
|
N.P. Belyak (1, 2), R.V. Orlova (1, 2), S.I. Kutukova (1, 3), N.V. Zhukova (1, 2), S.A. Borozdina (2)
Evaluation of the effectiveness of adjuvant chemotherapy for locally advanced gastric cancer in real clinical practice
|
41-45 |
S.S. Ereschenko, V.F. Semiglazov, P.V. Krivorotko, G.A. Dashyan, V.O. Smirnova, A.V. Komyakhov, L.P. Gigolaeva, E.K. Zhiltsova
Treatment of residual breast cancer
|
46-52 |
L.Yu. Vladimirova, N.A. Abramova, I.L. Popova, K.A. Novoselova, N.M. Tikhanovskaya, L.A. Ryadinskaya, A.A. Lyanova, V.S. Myagkova, M.A. Teplyakova, A.E. Storozhakova, E.A. Kalabanova, N.Yu. Samaneva, S.N. Kabanov, Y.V. Svetitskaya, A.V. Tishina, L.K. Strakhova, M.O. Yezhova
The combination of gemcitabine and nab-paclitaxel in patients with locally advanced and advanced pancreatic cancer
|
53-57 |
A.P. Oganesyan (1), S.A. Protsenko (1), I.A. Baldueva (1), A.V. Novik (1, 2), D.Kh. Latipova (1), A.I. Semenova (1), G.M. Teletaeva (1)
Comparison of systems for evaluating the effectiveness of modern immunotherapy
|
58-61 |
S.I. Kutukova (1, 2), A.B. Chukhlovin (1), A.I. Yaremenko (1), N.P. Belyak (1, 3), Yu.V. Ivaskova (1, 2), A.Ya. Razumova (1), T.S. Ermakova (2)
Survival analysis of patients with oral squamous cell carcinoma in association with DNA of the main types of oncogenic oral viruses
|
62-67 |
M.S. Knyazeva, V.A. Zagoruyko, E.V. Borisov, E.I. Sidina, N.S. Nikiforova, M.A. Slyusarenko, I.V. Nazarova, A.I. Semenova, A.K. Nosov, S.A. Protsenko, A.V. Malek
Evaluation of the effectiveness and the possibility of optimizing the methodology for analyzing the plasma microRNA-371-3 (HSA-miR-371-3p) level for the diagnosis and monitoring of the effect of therapy of germ cell tumors in men
|
68-75 |
K.O. Kondratyeva, T.Yu. Semiglazova, B.S. Kasparov, M.V. Vagaitseva, V.A. Klyuge
Antivital experiences of oncologic patients against the background of antitumor treatment and in the long term period
|
76-80 |
V.A. Chubenko
Metronome therapy: a new rhythm – new opportunities
|
81-84 |
L.V. Filatova (1, 2)
Immunotherapy of diffuse large B-cell lymphoma
|
85-95 |
T.Yu. Semiglazova (1, 2), O.A. Volynshchikova (1), V.V. Semiglazov (1, 3), V.V. Klimenko (1), N.A. Brish (1), Yu.V. Alekseeva (1), V.A. Klyuge (1), A.A. Krutov (1), R.M. Paltuev (1), B.S. Kasparov (1), P.V. Krivorotko (1, 2), V.F. Semiglazov (1, 2)
Abemacyclib – new options for the treatment of hormone- positive metastatic breast cancer with CDK4/6 inhibitors
|
96-103 |
D.O. Yurlov, S.A. Protsenko, I.A. Baldueva
Predictive and prognostic markers in the treatment of patients with solid tumors
|
104-110 |
V.I. Gorbachev (1), M.V. Burikov (2), R.A. Lepetyukhin (2), D.V. Morozov (3), S.M. Gorbacheva (1), E.S. Netesin (1)
Legal and clinical aspects of opioid analgesics
|
111-115 |
S.A. Protsenko (1), E.M. Anokhina (2), R.V. Orlova (3, 4)
The experience of using the combined targeted regimen vemurafenib+cobimetinib in the treatment of metastatic skin melanoma with a BRAF V600E mutation in a patient with HIV infection receiving antiretroviral therapy
|
116-123 |
G.A. Khakimov (1, 2), Zh.B. Sadullaev (1, 2), G.G. Khakimova (3)
Difficulties in diagnosing primary pulmonary Hodgkin’s lymphoma. Case report
|
124-127 |